Eli Lilly 2012 Annual Report Download - page 107

Download and view the complete annual report

Please find page 107 of the 2012 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 164

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164

3
Director compensation
Our independent directors receive cash compensation in the form of an annual retainer ($100,000), with additional
annual amounts for the lead director ($30,000), committee chairs ($12,000 to $18,000, depending on the
committee), and directors who serve on the audit committee or the science and technology committee ($3,000). In
addition, each independent director receives $145,000 in shares of company stock each year, payable after service
on the board has ended. Additional information about director compensation can be found under “Director
Compensation” below.
Contacting the board of directors
You may send written communications to one or more members of the board, addressed to:
Board of Directors
Eli Lilly and Company
c/o Corporate Secretary
Lilly Corporate Center
Indianapolis, Indiana 46285
All such communications (from shareholders or other interested parties) will be forwarded to the relevant
director(s), except for solicitations or other matters unrelated to the company.
Executive Compensation
Our compensation philosophy is designed to attract and retain highly-talented individuals and motivate them to
create long-term shareholder value by achieving top-tier corporate performance while embracing the company’s
values of integrity, excellence, and respect for people. Our programs seek to:
• closely link compensation with company performance and individual performance
• foster a long-term focus
• provide compensation consistent with the level of job responsibility and the market for pharmaceutical
talent
• be efficient and egalitarian
• appropriately mitigate risk
• consider shareholder input.
For a detailed discussion of our executive compensation programs and how they reflect our philosophy and are
linked to company performance, please see “Compensation Discussion and Analysis” below.